新型ACC抑制剂用于治疗
1Smith, Gambrell & Russell LLP, 1105 W. Peachtree Street NE, Suite 1000, Atlanta, Georgia 30309, United States.
ACS medicinal chemistry letters
|April 17, 2024
概括
新型的乙-甲氧酶 (ACC) 抑制剂为治疗提供了一种新的治疗方法. 这些创新的化合物及其制备方法是详细的,为有效的治疗铺平了道路.
科学领域:
- 生物化学 生物化学
- 皮肤病学 皮肤病学
- 药用化学 医学化学
背景情况:
- 一般性是一种常见的皮肤疾病,具有重大影响.
- 目前治疗的方法有局限性和副作用.
- 针对特定的生化途径为新疗法提供了潜在的潜力.
研究的目的:
- 为了引入新型的乙-CoA碳氧化酶 (ACC) 抑制剂.
- 描述含有这些抑制剂的药物成分.
- 概述这些化合物在治疗和它们的制备中的使用.
主要方法:
- 新型ACC抑制剂的合成和表征.
- 制药成分的配方. 制药成分的配方.
- 评估疗效的体外和/或体内研究 (详细信息未提供摘要).
主要成果:
- 鉴定具有ACC抑制活性的新型化合物.
- 在治疗中展示潜在的治疗效用 (具体结果没有详细说明).
- 开发可扩展的过程,用于制备化合物.
结论:
- 新型ACC抑制剂代表了治疗的有希望的新类药物.
- 描述的药物成分和制备方法支持临床开发.
- 需要进一步的研究,以充分阐明治疗潜力和安全性.
相关概念视频
Alkylation of β-Ketoester Enolates: Acetoacetic Ester Synthesis
3.3K
Acetoacetic ester synthesis is a method to obtain ketones from alkyl halides and β-keto esters. The reaction occurs in the presence of an alkoxide base that abstracts the acidic proton of the β-keto esters. The step results in an enolate ion which is doubly stabilized. The enolate then reacts with an alkyl halide via the SN2 process to produce an alkylated ester intermediate with a new C–C bond. The hydrolysis of the intermediate, followed by acidification, results in an...
3.3K
Loss of Carboxy Group as CO2: Decarboxylation of β-Ketoacids
3.2K
Carboxylic acids, upon heating, undergo a decarboxylation reaction by releasing carbon dioxide gas. Monocarboxylic acids do not undergo decarboxylation easily. However, a silver salt of carboxylic acid reacts with bromine or iodine under high temperature to release carbon dioxide gas and forms halide with one less carbon. This reaction is called the Hunsdiecker reaction.
3.2K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
655
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
655
Reactions of Carboxylic Acids: Introduction
3.0K
Carboxylic acids possess an acidic –COOH functional group. The acidity can be attributed to the resonance stabilization of their conjugate base, wherein the negative charge is delocalized over both oxygen atoms.
3.0K
Phase II Reactions: Acetylation Reactions
223
Acetylation, a phase II biotransformation reaction, introduces an acetyl group to drugs or their metabolites. Acetyltransferase enzymes facilitate this reaction, which resembles α-amino acid conjugation due to the addition of a functional group to the drug molecule.
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
223
Loss of Carboxy Group as CO2: Decarboxylation of Malonic Acid Derivatives
2.0K
Just like β-keto acids—which upon thermal decarboxylation form ketones—β-dicarboxylic acids undergo decarboxylation to generate monocarboxylic acids with the liberation of carbon dioxide.
2.0K


